Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Eli Lilly & Co. (NYSE:LLY)

Analysis of Liquidity Ratios

Beginner level

Liquidity Ratios (Summary)

Eli Lilly & Co., liquidity ratios

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Current ratio 1.40 1.16 1.73 1.32 1.37
Quick ratio 0.85 0.68 1.20 0.91 0.98
Cash ratio 0.29 0.21 0.68 0.55 0.55

Based on: 10-K (filing date: 2021-02-17), 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21).

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Eli Lilly & Co.’s current ratio deteriorated from 2018 to 2019 but then slightly improved from 2019 to 2020.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Eli Lilly & Co.’s quick ratio deteriorated from 2018 to 2019 but then slightly improved from 2019 to 2020.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Eli Lilly & Co.’s cash ratio deteriorated from 2018 to 2019 but then slightly improved from 2019 to 2020.

Current Ratio

Eli Lilly & Co., current ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in thousands)
Current assets 17,462,100  13,709,600  20,549,600  19,202,100  15,101,400 
Current liabilities 12,481,600  11,775,200  11,888,100  14,535,900  10,986,600 
Liquidity Ratio
Current ratio1 1.40 1.16 1.73 1.32 1.37
Benchmarks
Current Ratio, Competitors2
Abbott Laboratories 1.72 1.44 1.62 2.26 4.02
AbbVie Inc. 0.84 3.18 0.98 1.28 1.65
Amgen Inc. 1.81 1.44 2.79 5.49 4.11
Bristol-Myers Squibb Co. 1.58 1.60 1.61 1.55 1.55
Gilead Sciences Inc. 3.10 3.38 2.74 2.22
Illumina Inc. 3.60 6.69 2.49 3.99 3.29
Johnson & Johnson 1.21 1.26 1.47 1.41 2.47
Merck & Co. Inc. 1.24 1.17 1.33 1.78
Pfizer Inc. 0.88 1.57 1.35 1.25
Regeneron Pharmaceuticals Inc. 3.63 3.67 4.47 3.82 2.56
Vertex Pharmaceuticals Inc. 4.33 3.61 3.43 3.28 2.31
Zoetis Inc. 3.05 2.63 3.60 3.85 3.03
Current Ratio, Sector
Pharmaceuticals & Biotechnology 1.57 1.73 1.82 2.10
Current Ratio, Industry
Health Care 1.49 1.52 1.61 1.75

Based on: 10-K (filing date: 2021-02-17), 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21).

1 2020 Calculation
Current ratio = Current assets ÷ Current liabilities
= 17,462,100 ÷ 12,481,600 = 1.40

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Eli Lilly & Co.’s current ratio deteriorated from 2018 to 2019 but then slightly improved from 2019 to 2020.

Quick Ratio

Eli Lilly & Co., quick ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in thousands)
Cash and cash equivalents 3,657,100  2,337,500  7,998,200  6,536,200  4,582,100 
Short-term investments 24,200  101,000  88,200  1,497,900  1,456,500 
Accounts receivable, net of allowances 5,875,300  4,547,300  5,246,500  4,546,300  4,029,400 
Other receivables 1,053,700  994,200  958,400  715,900  736,900 
Total quick assets 10,610,300  7,980,000  14,291,300  13,296,300  10,804,900 
 
Current liabilities 12,481,600  11,775,200  11,888,100  14,535,900  10,986,600 
Liquidity Ratio
Quick ratio1 0.85 0.68 1.20 0.91 0.98
Benchmarks
Quick Ratio, Competitors2
Abbott Laboratories 1.14 0.88 1.03 1.67 3.31
AbbVie Inc. 0.60 2.91 0.78 0.89 1.14
Amgen Inc. 1.30 1.01 2.44 4.98 3.68
Bristol-Myers Squibb Co. 1.28 1.26 1.37 1.30 1.27
Gilead Sciences Inc. 2.86 3.15 2.52 1.78
Illumina Inc. 3.18 6.00 2.23 3.43 2.75
Johnson & Johnson 0.91 0.94 1.08 1.04 2.04
Merck & Co. Inc. 0.78 0.72 0.83 1.24
Pfizer Inc. 0.50 0.84 0.93 0.84
Regeneron Pharmaceuticals Inc. 2.86 2.81 3.50 2.98 2.13
Vertex Pharmaceuticals Inc. 4.02 3.33 3.19 2.94 2.06
Zoetis Inc. 2.13 1.67 2.24 2.34 1.47
Quick Ratio, Sector
Pharmaceuticals & Biotechnology 1.18 1.28 1.41 1.64
Quick Ratio, Industry
Health Care 1.13 1.12 1.24 1.35

Based on: 10-K (filing date: 2021-02-17), 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21).

1 2020 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 10,610,300 ÷ 12,481,600 = 0.85

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Eli Lilly & Co.’s quick ratio deteriorated from 2018 to 2019 but then slightly improved from 2019 to 2020.

Cash Ratio

Eli Lilly & Co., cash ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 31, 2020 Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016
Selected Financial Data (US$ in thousands)
Cash and cash equivalents 3,657,100  2,337,500  7,998,200  6,536,200  4,582,100 
Short-term investments 24,200  101,000  88,200  1,497,900  1,456,500 
Total cash assets 3,681,300  2,438,500  8,086,400  8,034,100  6,038,600 
 
Current liabilities 12,481,600  11,775,200  11,888,100  14,535,900  10,986,600 
Liquidity Ratio
Cash ratio1 0.29 0.21 0.68 0.55 0.55
Benchmarks
Cash Ratio, Competitors2
Abbott Laboratories 0.60 0.38 0.45 1.08 2.82
AbbVie Inc. 0.30 2.56 0.47 0.59 0.66
Amgen Inc. 0.91 0.69 2.17 4.62 3.40
Bristol-Myers Squibb Co. 0.83 0.84 0.83 0.71 0.72
Gilead Sciences Inc. 2.50 2.84 2.19 1.29
Illumina Inc. 2.79 5.13 1.95 2.88 2.21
Johnson & Johnson 0.59 0.54 0.63 0.60 1.59
Merck & Co. Inc. 0.47 0.40 0.46 0.83
Pfizer Inc. 0.26 0.59 0.66 0.57
Regeneron Pharmaceuticals Inc. 1.33 1.53 1.95 1.24 0.84
Vertex Pharmaceuticals Inc. 3.55 2.85 2.83 2.59 1.81
Zoetis Inc. 1.66 1.07 1.39 1.43 0.65
Cash Ratio, Sector
Pharmaceuticals & Biotechnology 0.81 0.90 1.01 1.23
Cash Ratio, Industry
Health Care 0.73 0.72 0.85 0.94

Based on: 10-K (filing date: 2021-02-17), 10-K (filing date: 2020-02-19), 10-K (filing date: 2019-02-19), 10-K (filing date: 2018-02-20), 10-K (filing date: 2017-02-21).

1 2020 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 3,681,300 ÷ 12,481,600 = 0.29

2 Click competitor name to see calculations.

Liquidity ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Eli Lilly & Co.’s cash ratio deteriorated from 2018 to 2019 but then slightly improved from 2019 to 2020.